Bonu', Marco Lorenzo Furio
 Distribuzione geografica
Continente #
NA - Nord America 2.375
AS - Asia 1.155
EU - Europa 921
SA - Sud America 181
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 31
OC - Oceania 2
Totale 4.726
Nazione #
US - Stati Uniti d'America 2.298
SG - Singapore 424
IT - Italia 327
CN - Cina 304
BR - Brasile 148
DE - Germania 135
HK - Hong Kong 124
VN - Vietnam 81
BD - Bangladesh 80
PL - Polonia 66
UA - Ucraina 66
FR - Francia 59
FI - Finlandia 58
GB - Regno Unito 56
RU - Federazione Russa 41
TR - Turchia 39
CA - Canada 36
IN - India 35
IE - Irlanda 31
NL - Olanda 15
IQ - Iraq 13
CZ - Repubblica Ceca 12
MX - Messico 12
AR - Argentina 11
ES - Italia 11
ID - Indonesia 10
ZA - Sudafrica 9
MA - Marocco 7
SA - Arabia Saudita 7
SE - Svezia 7
EC - Ecuador 6
JM - Giamaica 6
TN - Tunisia 6
PK - Pakistan 5
AL - Albania 4
CO - Colombia 4
EG - Egitto 4
JP - Giappone 4
LT - Lituania 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BE - Belgio 3
BZ - Belize 3
CH - Svizzera 3
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
KE - Kenya 3
NP - Nepal 3
PH - Filippine 3
PR - Porto Rico 3
VE - Venezuela 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
CW - ???statistics.table.value.countryCode.CW??? 2
EU - Europa 2
JO - Giordania 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
SN - Senegal 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
Totale 4.669
Città #
Ashburn 282
Singapore 241
San Jose 183
Fairfield 177
Hong Kong 123
Chandler 111
Seattle 89
Houston 79
New York 78
Beijing 74
Wilmington 67
Los Angeles 66
Woodbridge 64
Warsaw 63
Council Bluffs 60
Jacksonville 60
The Dalles 58
Brescia 55
Cambridge 53
Munich 50
Helsinki 49
Milan 47
Princeton 42
Dallas 32
Dublin 31
Ho Chi Minh City 31
Lauterbourg 31
Istanbul 28
Santa Clara 26
Columbus 21
North Bergen 21
Ann Arbor 19
Buffalo 19
Shanghai 19
Chicago 17
San Francisco 17
Des Moines 16
Frankfurt am Main 15
San Diego 15
São Paulo 15
Dearborn 14
Orem 13
Phoenix 13
Hanoi 12
Naples 12
Verona 12
Atlanta 11
Denver 11
Redondo Beach 11
Washington 11
Boardman 10
Moscow 10
Toronto 10
Brooklyn 9
Jakarta 9
Nanjing 9
Nuremberg 9
Rome 9
Chennai 8
Dong Ket 8
London 8
Brno 7
Changsha 7
Montreal 7
Newark 7
Romola 7
Mexico City 6
Turku 6
Bengaluru 5
Catania 5
Erbil 5
New Delhi 5
Paris 5
Philadelphia 5
Turin 5
Ankara 4
Augusta 4
Cairo 4
Cremona 4
Curitiba 4
Delhi 4
Haiphong 4
Johannesburg 4
Kilburn 4
Kingston 4
Lumezzane 4
Miami 4
Poplar 4
Shenyang 4
Tashkent 4
Tokyo 4
Amsterdam 3
Athens 3
Bangkok 3
Biên Hòa 3
Boston 3
Brasília 3
Brussels 3
Cagliari 3
Calvisano 3
Totale 2.936
Nome #
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 237
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 237
Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist 216
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 181
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 171
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 168
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 168
18F-Fluciclovine (18F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas 166
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 158
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 157
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 156
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 153
18F-FDG PET or PET/CT role in plasmacytoma: A systematic review 151
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 146
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 142
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 138
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 137
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 131
Skull base osteomyelitis: clinical and radiologic analysis of a rare and multifaceted pathological entity 128
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 122
Mr-guided hypofractionated radiotherapy: Current emerging data and promising perspectives for localized prostate cancer 114
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 111
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer 110
Impact of Dosimetric Parameters on Tumor Control in Stereotactic Radiotherapy for Pancreatic Cancer: A Prospective Study on 104 Patients Treated with Simultaneous Integrated Protection (SIP) 109
Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging 109
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 103
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience 100
Radiolabelled PSMA PET/CT in breast cancer. A systematic review 100
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 94
Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases 92
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 79
Microbiota Modulation of Radiosensitiveness and Toxicity in Gastrointestinal Cancers: What Radiation Oncologists Need to Know—A Review on Behalf of the Italian Association of Radiobiology (AIRB) 71
Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity 71
The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer 68
Stereotactic Radiotherapy and Androgen Deprivation Therapy for Localized Prostate Cancer: A Retrospective Mono-institutional Experience 61
First Report of a Noncomplete Clinical Response to Dostarlimab in Locally Advanced Rectal Cancer: Insights into Patient-Related Factors and Implications for Future Therapeutic Management 27
Primary Adrenal Malignancies 25
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water! 19
Totale 4.726
Categoria #
all - tutte 24.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022145 0 0 0 8 2 12 4 17 8 28 11 55
2022/2023298 31 12 14 23 26 73 9 27 42 2 28 11
2023/2024448 20 7 50 18 27 85 18 40 70 19 35 59
2024/2025732 15 16 11 107 54 65 48 34 92 70 141 79
2025/20261.709 146 170 93 216 161 128 232 72 116 173 115 87
2026/2027462 55 57 102 248 0 0 0 0 0 0 0 0
Totale 4.726